Form 4 holding
EVP & Head of Research & Product Development
Ascendis Pharma A/S
- Security class
- Ordinary Shares
- Shares / value
- 19,460
- Estimated value
- $4,572,905
- Report date
- 18 Mar 2026
- Price
- $234.99
- Ownership
- Direct